A team at Rutgers University has developed a new rapid screening test for omicron and other coronavirus variants of concern. The test, which is up for clinical approval, could guide treatment of COVID-19 patients and detect potentially severe cases.
Dr. Priya Banada, assistant professor of research at Rutgers New Jersey Medical School, who served as the project leader, discusses the development of the test.
